ArticleDiscover oncology2025
Bibliometric insights into molecular and bioinformatic research trends on ameloblastoma.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe study aimed to evaluate the significant trends of advancement in the body of literature of specialty journals on molecular biological investigations of ameloblastoma (AB). Additionally, this bibliometric study sought to identify the authors, organizations, journals, and countries from emerging regions that have exerted the most significant influence on molecular biological and bioinformatics studies on AB. NOVELTY OF STUDY: The novelty of this study lies in its comprehensive bibliometric integration of bioinformatics and molecular perspectives, offering a structured roadmap for future ameloblastoma research. MATERIALS AND
methodsA complete list of AB molecular biological research citations was found in Scopus. The search was restricted to papers published between 2014 and 2024, but there were no restrictions on the language or type of research studies. The study examined total citations, citation density, journal name, impact factor, journal category, quartile, published year, authors, affiliations, and study type.
resultsThe analysis included collecting 112 publications published between 2014 and 2024. There were 95 original research papers, 6 systematic reviews, 5 case reports, 3 brief communications, and 6 systematic reviews and meta-analyses. Our analysis identifies noteworthy authors and nations that have contributed, with Brazil emerging as a leading figure in this field of study.
conclusionsThe research on AB, especially its biological profile, has changed significantly across the years, as can be observed by perusing the contents of the papers included here. The data from this study would help the researchers target specific objectives for future research in more relevant avenues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.